Gemcitabine

Pancreatic cancer: The Lancet: January 24, 2017

Listen to The Lancet

9 years ago

Pancreatic cancer: The Lancet: January 24, 2017

pancreatic cancer

chemotherapy

gemcitabine

capecitabine

espac

+5

+5

+4

+4

+4

+3

+3

+3

+2

pancreatic cancer

chemotherapy

gemcitabine

capecitabine

espac

+5

+5

+4

+4

+4

+3

+3

+3

+2

Optimizing Treatment Strategies for Germline BRCA/PALB2 Mutant Pancreatic Adenocarcinoma

Journal of Clinical Oncology P

6 years ago

Optimizing Treatment Strategies for Germline BRCA/PALB2 Mutant Pancreatic Adenocarcinoma

pancreatic

adenocarcinoma

cisplatin

gemcitabine

brca

+5

+4

+4

+4

+3

+3

+2

+2

pancreatic

adenocarcinoma

cisplatin

gemcitabine

brca

+5

+4

+4

+4

+3

+3

+2

+2

Squamous Lung Cancer Part 5, Q and A Session (audio)

GRACEcast Lung Cancer Audio

12 years ago

Squamous Lung Cancer Part 5, Q and A Session (audio)

grace

cancergrace

kras

bevacizumab

gemcitabine

+4

+4

+4

+3

+2

+2

+2

+1

grace

cancergrace

kras

bevacizumab

gemcitabine

+4

+4

+4

+3

+2

+2

+2

+1

Journal of Clinical Oncology P

14 years ago

Combinations or Single Agents, Crossover or No Crossover: Considering Chemotherapy Strategies in the

docetaxel

gemcitabine

metastaticbreastcancer

chemotherapystrategies

+4

+3

+3

+3

+2

+2

+2

+1

docetaxel

gemcitabine

metastaticbreastcancer

chemotherapystrategies

+4

+3

+3

+3

+2

+2

+2

+1